Root Causes of SIBO: Why Does Overgrowth Happen?

Small intestinal bacterial overgrowth (SIBO) is a condition in which an abnormally high number of bacteria populate the small intestine. In a healthy human body, the vast majority of gut bacteria live in the large intestine, which is also called the colon. The small intestine is designed to digest food and absorb nutrients. Because of this specialized role, the small intestine requires a relatively clean environment with low bacterial counts. When bacteria multiply excessively in the small intestine, they ferment the carbohydrates a person eats before the body can absorb them. This fermentation creates large amounts of gas and toxic byproducts, which leads to bloating, abdominal pain, diarrhea, constipation, and malnutrition.
SIBO is not a disease that happens by chance. It occurs when the body’s natural defense systems fail¹. The digestive tract relies on a complex network of physical, chemical, and immune mechanisms to control bacterial populations and prevent colon bacteria from moving backward into the small intestine. To understand the causes of SIBO, it is necessary to examine how these specific protective barriers break down. The underlying causes generally fall into a few main categories: failures in digestive movement, reduced digestive juices, physical abnormalities in the intestines, and immune system dysfunction.

The Body’s Natural Defense Mechanisms

To understand how SIBO develops, it helps to understand how the body normally prevents it. The digestive tract uses several overlapping barriers to keep the small intestine clean.
The first defense is stomach acid. The stomach produces hydrochloric acid, which sterilizes the food and liquids a person consumes⁴. This highly acidic fluid destroys most ingested bacteria, preventing them from surviving the journey into the small intestine⁵. Further down the digestive tract, the pancreas and the liver release digestive enzymes and bile into the upper small intestine. Enzymes that break down proteins also degrade bacterial cell walls, while bile acts as a detergent that limits bacterial growth⁶.
The primary physical defense is a movement pattern called the migrating motor complex. When a person is fasting, such as between meals or while sleeping, the stomach and small intestine generate organized, wave-like muscle contractions⁴. These contractions sweep through the digestive tract, pushing undigested food, cellular waste, and residual bacteria down into the large intestine⁴.
Another physical barrier is the ileocecal valve. This valve is located where the lower small intestine connects to the beginning of the large intestine. It functions as a one-way door. It opens to let waste exit the small intestine, and then it closes tightly to prevent the dense bacteria of the colon from washing backward⁶.
Finally, the body uses an immunological barrier. The lining of the gastrointestinal tract secretes an antibody called secretory immunoglobulin A. This antibody binds to bacteria, which stops the bacteria from attaching to the walls of the intestine and neutralizes their ability to grow into large colonies¹. SIBO develops when one or more of these chemical, mechanical, or immune barriers are compromised³.

Failures of Gastrointestinal Motility

Disrupted gastrointestinal motility, meaning a failure in how the digestive tract moves, is the most common cause of small intestinal bacterial overgrowth¹. When the physical movement of the intestines slows down, bacteria have the time and the environment to multiply and establish colonies in the small intestine.

The Disruption of the Migrating Motor Complex

The migrating motor complex is a specific muscle pattern that only occurs when the digestive tract is empty. It is controlled by the enteric nervous system, which is a network of nerves embedded directly in the lining of the gut. A hormone called motilin helps stimulate this process⁷. The migrating motor complex operates in four phases. The most important is phase III, which consists of strong, regular contractions that start in the stomach and travel all the way through the small intestine⁴.
Phase III acts as the primary “housekeeper” of the intestines. It physically sweeps the small intestine clean approximately every 90 to 120 minutes while a person is fasting¹. When a person eats, this sweeping motion stops immediately, and normal digestive churning takes over. Studies indicate that patients with SIBO frequently lack a functioning phase III migrating motor complex⁴. Without these sweeping waves, food debris and bacteria sit stagnant in the small intestine. Diagnostic studies using wireless motility capsules confirm that SIBO is directly linked to this slowed transit time in the small intestine³.

Post-Infectious Autoimmunity

One of the most well-documented causes of migrating motor complex failure is post-infectious autoimmunity. This process usually begins with a common case of food poisoning¹¹. When a person eats food contaminated with bacteria like Campylobacter jejuni, Salmonella, Escherichia coli, or Shigella, they develop a stomach infection¹³. These specific bacteria produce a toxin called cytolethal distending toxin B¹³.
When the human immune system detects this toxin, it produces antibodies to fight the infection¹¹. However, the physical shape of the bacterial toxin is very similar to a protein naturally found in the human body called vinculin¹¹. Vinculin helps connect specialized nerve cells in the gut, known as the interstitial cells of Cajal. These cells act as the electrical pacemakers that generate the sweeping waves of the migrating motor complex¹¹.
Because the bacterial toxin and the human vinculin protein look so similar, the immune system becomes confused. The antibodies created to fight the food poisoning begin to attack the body’s own pacemaker cells¹¹. This autoimmune attack damages the nerves in the gut wall. As these pacemaker cells are damaged, the migrating motor complex becomes weak or stops¹¹. This damage causes intestinal stasis, which allows bacteria to accumulate in the small intestine. The symptoms of SIBO caused by this mechanism often appear several months after the food poisoning event, long after the original infection has passed¹¹.

Metabolic and Neurological Disorders

Any medical condition that damages the nerves or muscles of the digestive tract can impair the migrating motor complex and cause SIBO. Diabetes is a major risk factor³. Over many years, chronic high blood sugar damages the blood vessels that supply nerves throughout the body. When this nerve damage affects the digestive system, it causes a condition called visceral neuropathy⁵. This impairs the nerves responsible for coordinating stomach emptying and small intestine movement³. The prevalence of SIBO increases significantly in diabetic patients, particularly those who experience chronic diarrhea¹.
Neurological conditions that affect the brain and spinal cord also increase the risk of SIBO. Parkinson’s disease involves the breakdown of dopamine-producing neurons, which affects movement throughout the entire body, including the gut. Patients with Parkinson’s disease frequently experience delayed stomach emptying and prolonged intestinal transit times, which provides bacteria with the opportunity to colonize⁵. Multiple sclerosis and myotonic dystrophy are also known causes, as these conditions disrupt normal nerve signaling and muscle function³.

Connective Tissue Diseases

Systemic sclerosis, commonly known as scleroderma, is an autoimmune disorder where the body produces too much collagen, forming stiff scar tissue in the skin and internal organs. When systemic sclerosis affects the digestive tract, the normal, flexible muscle tissue of the intestinal wall is slowly replaced by rigid, non-functioning scar tissue³. Patients with systemic sclerosis also develop antibodies that block specific nerve receptors in the gut muscles³. This loss of muscle flexibility and nerve function severely slows intestinal movement, leading to high rates of SIBO³. Amyloidosis, a disease where abnormal proteins build up in tissues, similarly stiffens the nerves and muscles of the gut and is associated with delayed bacterial clearance³.

Medication-Induced Causes

Certain medications chemically slow the movement of the gastrointestinal tract. Prescription opioid pain medications are well-known for causing severe constipation. They bind to receptors in the gut wall, directly stopping the migrating motor complex and slowing the transit of food and waste⁵. Anticholinergic drugs, which are prescribed for conditions like overactive bladder and depression, block a chemical called acetylcholine. Acetylcholine is the main messenger that tells the digestive muscles to contract. Long-term use of these medications reduces the activity of the migrating motor complex, increasing the risk of bacterial stagnation⁵.

Altered Digestive Secretions

Bacteria need a friendly environment to survive. The stomach and pancreas normally release fluids that make the upper digestive tract hostile to bacteria. When these fluids are reduced, the environment becomes highly favorable for bacterial overgrowth.

Low Stomach Acid

The normal environment of the stomach is highly acidic, which kills swallowed bacteria and keeps bacterial counts very low in the upper small intestine¹. Hypochlorhydria is the medical term for low stomach acid, and achlorhydria means a complete lack of stomach acid. When stomach acid levels fall, bacteria from the mouth and from food survive the trip through the stomach and colonize the small intestine⁴.
Stomach acid production naturally decreases in some individuals as they age, making the elderly more susceptible to SIBO¹. Acid production is also reduced by Helicobacter pylori, a common type of bacteria that infects the stomach lining and neutralizes stomach acid to protect itself¹.
The most common modern cause of low stomach acid is the widespread use of acid-blocking medications, particularly proton pump inhibitors and histamine type 2 receptor blockers¹. These medications are taken to treat acid reflux and stomach ulcers. By intentionally shutting down the acid-producing pumps in the stomach, these drugs change the environment of the gut. Multiple reviews of medical studies show a clear statistical link between the use of proton pump inhibitors and an increased risk of SIBO¹⁸. The risk depends heavily on how long the patient takes the medication. Patients who use these drugs continuously for more than six months are much more likely to develop bacterial overgrowth compared to those on short-term therapy²¹.

Pancreatic and Liver Insufficiency

The pancreas releases digestive enzymes, and the liver produces bile. Both fluids mix with food as it enters the first section of the small intestine. In addition to digesting food, these enzymes break down bacterial cell walls, and bile acts like an antimicrobial soap⁶.
Chronic pancreatitis is a condition where the pancreas is permanently damaged by inflammation. This damage stops the pancreas from producing enough digestive enzymes. Without these enzymes, bacteria are not destroyed, and undigested food stays in the intestinal tract longer, providing a large food supply for any surviving bacteria⁴. Medical studies show that the prevalence of SIBO in patients with chronic pancreatitis is roughly 25 percent, and it rises to over 50 percent if those patients have also had gastrointestinal surgery⁵. Liver diseases, such as cirrhosis, also increase the risk of SIBO by reducing bile flow and causing portal hypertension, which swells the blood vessels in the gut and slows intestinal transit²².

Structural and Anatomical Abnormalities

The physical shape of the small intestine is built for the rapid, clear flow of food and waste. Any physical change that creates a blockage, a narrow spot, or a blind pocket allows contents to pool and stagnate⁵. Bacteria multiply very quickly in these stagnant areas.

Surgical Alterations and Blind Loops

Surgeries performed on the stomach for weight loss or ulcer treatment frequently change the natural routing of the digestive tract. SIBO is so strongly connected to these procedures that doctors historically called it “blind loop syndrome”²³.
A common example is the Billroth II procedure, where part of the stomach is removed and the remainder is connected directly to the middle of the small intestine. This surgery leaves the first part of the small intestine, the duodenum, intact but bypassed by the flow of food. This bypassed section becomes a “blind loop”⁸. Secretions from the liver and pancreas still flow into this blind loop, but without the physical bulk of food passing through to sweep it clean, the fluids sit and stagnate. This provides a perfect breeding ground for bacteria⁸. Gastric bypass surgery creates a similar bypassed loop that lacks normal transit flow, directly causing bacterial stasis⁵.

Strictures and Adhesions

Strictures are abnormal narrowings inside the intestinal tube. They act like a traffic bottleneck, slowing the movement of food and causing material to back up into the section of the intestine right before the stricture. This delay gives bacteria ample time to ferment the trapped food⁵.
Strictures are often caused by Crohn’s disease, a condition that causes deep inflammation in the intestinal wall⁵. Over time, this chronic inflammation causes the wall to thicken and become stiff, which narrows the passageway. Radiation therapy for abdominal cancers can also cause scar tissue that narrows the intestine²³.
Post-operative adhesions are bands of scar tissue that form between internal organs after abdominal surgery⁶. These bands can wrap around the outside of the small intestine, pinching or kinking it. Like a stricture inside the tube, an adhesion on the outside creates a partial blockage that leads to bowel stasis⁶.

Small Intestinal Diverticulosis

Diverticulosis is a condition where small, balloon-like pouches of tissue push outward through weak spots in the muscular wall of the intestine⁶. While these pouches are most common in the large intestine, they can also form in the small intestine³. These pouches sit outside the main flow of the intestinal tube. When the migrating motor complex sweeps the intestine, it cannot reach into these pouches to clear out debris⁵. The pouches trap food particles and bacteria, allowing the bacteria to grow undisturbed and continuously release new bacteria into the rest of the small intestine⁵.

Ileocecal Valve Dysfunction

The ileocecal valve is the physical barrier between the small and large intestines. The large intestine holds trillions of bacteria, while the small intestine holds very few. The valve maintains this balance by remaining closed most of the time, opening only to let waste leave the small intestine⁶.
If the ileocecal valve becomes weak or damaged, it loses its resting pressure and fails to stay closed³. This failure allows the dense bacteria of the colon to wash backward into the small intestine⁶. Medical tests measuring the pressure of the valve show that low resting pressure is strongly associated with the presence of SIBO³.
Furthermore, some patients require the surgical removal of the ileocecal valve. This surgery is often necessary for patients with severe Crohn’s disease⁶. Once the valve is physically removed, the barrier is permanently gone. The bacterial makeup of the lower small intestine in these patients quickly becomes identical to that of the colon. Research shows that removing the ileocecal valve increases the likelihood of SIBO in Crohn’s patients to 30 percent or higher¹.

Immune System Dysfunction

The gastrointestinal tract has its own local immune system. Secretory immunoglobulin A is an antibody in the gut that provides the first line of immune defense against harmful microbes⁶. It coats bacteria and prevents them from sticking to the cells of the intestinal wall.
Patients with immune system disorders, especially those affecting antibody production, are highly prone to bacterial overgrowth¹. Hypogammaglobulinemia, a condition where the body has abnormally low levels of all antibodies, removes this defense mechanism, allowing bacteria to easily attach to the small intestine⁵. Similar mechanisms happen in patients with HIV or advanced malnutrition, where the immune response in the gut weakens, increasing the chance of SIBO even if the gut is moving normally¹.

How Specific Gases Cause Further Dysmotility

When discussing the causes of overgrowth, it is necessary to identify the types of organisms involved, as the gases they produce can actually become a cause of further intestinal slowing. Standard SIBO involves bacteria that produce hydrogen gas²⁶. However, another condition frequently grouped with SIBO is Intestinal Methanogen Overgrowth¹⁵.
Intestinal Methanogen Overgrowth is caused by archaea, which are single-celled organisms that are biologically different from bacteria. The most common methanogen in the human gut is Methanobrevibacter smithii¹⁵. Methanogens do not ferment food directly. Instead, they consume the hydrogen gas produced by other bacteria and use it to create methane gas²⁸.
Methane gas is not just a byproduct; it is an active molecule that changes how the body works. Animal and human studies show that methane gas acts as a paralyzing agent on the muscles of the digestive tract³⁰. Exposing intestinal tissue to methane decreases the speed of muscle contractions, effectively acting as a brake on the gut³³. In laboratory models, putting methane gas into the small intestine slows the movement of food by an average of 59 percent³².
This creates a vicious cycle. Patients with high levels of methanogens produce large amounts of methane. The methane gas directly slows down their intestinal motility and causes severe constipation²⁹. Because the gut is slowed down by the gas, the environment becomes even more stagnant, which allows the organisms to multiply even further²⁷. Patients with high methane levels are five times more likely to experience constipation compared to those with hydrogen gas, and the severity of the constipation matches the amount of methane produced²⁹.
Another specific gas is hydrogen sulfide, which is produced by bacteria such as Desulfovibrio. High levels of hydrogen sulfide cause visceral hypersensitivity, meaning the nerves in the gut become overly sensitive to pain, and it frequently triggers fluid secretion that leads to diarrhea¹⁶.

The Relationship Between SIBO and Irritable Bowel Syndrome

Irritable bowel syndrome (IBS) is a digestive disorder diagnosed based on a specific set of symptoms, such as abdominal pain, diarrhea, and constipation. It is diagnosed when doctors cannot find a visible structural disease¹³. Because the diagnosis of IBS is based entirely on symptoms, it describes what a patient is feeling rather than the underlying physical cause of the problem.
SIBO and IBS share identical symptoms. Both conditions cause severe bloating, distension, excess gas, cramping, and changes in bowel habits⁴. As breath testing has become more accurate, researchers have discovered that a large percentage of patients diagnosed with IBS actually have SIBO as the physical cause of their symptoms¹.
Studies show that the prevalence of SIBO in patients with IBS ranges from 31 percent to over 78 percent¹. The relationship between the two is largely defined by the mechanism of post-infectious autoimmunity. A patient gets food poisoning, and the body produces antibodies that accidentally damage the pacemaker cells of the gut¹¹. This nerve damage slows the migrating motor complex, resulting in a diagnosis of post-infectious IBS. The slowed movement then directly allows bacteria to overgrow, resulting in SIBO¹³.
This sequence of events explains why the two conditions overlap so frequently. Furthermore, the type of gas produced by the bacteria correlates directly with the type of IBS the patient has. Elevated hydrogen and hydrogen sulfide gases are strongly linked to IBS with diarrhea, while elevated methane gas is strongly linked to IBS with constipation¹⁵.

The Relationship Between SIBO and Leaky Gut

The lining of the small intestine is made of a single layer of cells. These cells absorb nutrients from food while acting as a security wall to keep bacteria, toxins, and undigested food particles inside the gut and out of the bloodstream. The tiny spaces between these cells are sealed tight by proteins called tight junctions. The term “leaky gut” refers to a state where these tight junctions break open, allowing unwanted substances to leak across the intestinal wall⁴.
SIBO is a direct physical cause of leaky gut⁴. The massive number of bacteria in the small intestine causes microscopic inflammation on the gut lining¹. Invasive bacteria produce toxins and enzymes that physically damage the surface cells of the intestine⁶. This damage causes the body to release a protein called zonulin. Elevated zonulin levels signal the tight junctions to dismantle, creating open gaps between the cells¹³.
Once the gut becomes leaky, the local problem in the digestive tract becomes a problem for the whole body. Undigested food particles and bacterial toxins slip through the gaps and enter the bloodstream. The body’s immune system detects these foreign particles and launches an attack against them⁴. This immune reaction causes the non-digestive symptoms that many SIBO patients experience, such as severe fatigue, joint pain, brain fog, and the sudden development of new food sensitivities⁴. Therefore, leaky gut is a mechanical consequence of the bacterial overgrowth and the damage it causes to the intestinal wall.

Determining the Underlying Causes

To achieve long-term relief from SIBO, physicians must determine exactly which defense mechanism failed and allowed the bacteria to overgrow¹. If the root cause is not identified, the bacteria will simply grow back after the patient finishes a round of antibiotics¹².
Physicians use specific diagnostic tests to trace SIBO back to its origin. To determine if a slowed gut is caused by post-infectious autoimmunity, blood tests can look for the presence of the anti-CdtB and anti-vinculin antibodies¹¹. High levels of these antibodies prove that nerve damage from a past food poisoning event is the reason the migrating motor complex has failed¹¹.
Breath testing is used to identify exactly which gases are present (hydrogen, methane, or hydrogen sulfide)²⁶. Knowing the gas type helps determine if the gut’s movement is being slowed down chemically by methane-producing archaea. Blood panels check thyroid function and fasting insulin to rule out metabolic causes like hypothyroidism or diabetes³⁸. Tests can also measure stomach acid levels to check for hypochlorhydria, while advanced imaging and endoscopy are used to search for structural causes like strictures, surgical blind loops, or a damaged ileocecal valve³⁸.

Mitigating and Managing the Causes

Treating SIBO is not just about clearing the bacteria; it is about mitigating the root cause so the bacteria cannot return¹. The management strategy depends entirely on which defense mechanism is broken.
When the primary cause is a broken migrating motor complex, management focuses on forcing the gut to move properly again. This is done using medications called prokinetics. Unlike standard laxatives, which only soften stool or stimulate the large intestine, prokinetic medications specifically stimulate the nerve receptors in the stomach and small intestine. This triggers the sweeping contractions of the migrating motor complex¹². Prokinetic therapy is usually taken at night before bed to help the gut clean itself out overnight¹².
Because the migrating motor complex only turns on when the stomach is empty, dietary management for a slow gut involves strict meal spacing. Patients are instructed to wait four to five hours between meals and to completely avoid snacking. This fasting window gives the nervous system the time it needs to initiate the cleaning waves⁴.
If the root cause is reduced digestive fluids, mitigation involves adjusting medications or replacing the missing fluids. If a patient developed SIBO because they take proton pump inhibitors for acid reflux, a doctor may help them slowly taper off the medication to bring their natural stomach acid back¹. If the cause is chronic pancreatitis, the patient must take prescription pancreatic enzymes with every meal to replace what their body cannot make⁴.
Structural causes of SIBO are the most difficult to manage because they involve physical changes to the anatomy. If a patient has severe strictures, fistulas, or surgical blind loops that constantly trap bacteria, they may require surgical revision to fix the anatomy and restore normal flow¹. If the physical anatomy cannot be fixed by surgery, such as in cases of severe scleroderma or a missing ileocecal valve, the cause cannot be permanently mitigated. In these specific cases, management relies on taking rotating courses of antibiotics to continually push the bacterial numbers back down, combined with nutritional supplements to treat the malnutrition caused by the overgrowth³.

Works Cited & Scientific References 38

▼

1. Small Intestinal Bacterial Overgrowth: A Comprehensive Review - PMC - NIH
2. Small Intestinal Bacterial Overgrowth (SIBO) Pathophysiology - News-Medical
3. Unraveling the Complexities of Small Intestinal Bacterial Overgrowth - PMC - NIH
4. SIBO: Causes, Symptoms & Treatment Options - OPA Cancer Charity
5. Aetiology, diagnosis and management of small intestinal bacterial overgrowth - PMC - NIH
6. Small Intestinal Bacterial Overgrowth - StatPearls - NCBI Bookshelf - NIH
7. The migrating motor complex: control mechanisms and its role in health and disease - PubMed
8. Small Intestinal Bacterial Overgrowth (SIBO) - Gastroenterology - MSD Manuals
9. Redefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling - PubMed
10. Microflora Modulation of Motility - PMC - NIH
11. What's the Best Functional Medicine Approach to SIBO Success? - Coho Health
12. Case Study: Recalcitrant Hydrogen and Methane SIBO in the Setting of Post-Infectious IBS
13. Cutoffs for anti-CdtB and anti-vinculin for the diagnosis of D-IBS vs. IBD - ResearchGate
14. Autoimmunity Links Vinculin to the Pathophysiology of Chronic Functional Bowel Changes Following Campylobacter jejuni Infection in a Rat Model - ResearchGate
15. Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome – An Update
16. Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications - MDPI
17. DIAGNOSIS AND TREATMENT OF SMALL INTESTINAL BACTERIAL OVERGROWTH: AN OFFICIAL POSITION PAPER FROM THE BRAZILIAN FEDERATION OF GASTROENTEROLOGY - PMC
18. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth - ProQuest
19. Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis - PubMed
20. Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth - PubMed
21. The Duration of Proton Pump Inhibitor Therapy and the Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis - PMC
22. Small Intestinal Bacterial Overgrowth in Patients With Cirrhosis - PMC
23. Small intestinal bacterial overgrowth (SIBO) - Symptoms & causes - Mayo Clinic
24. Asian-Pacific consensus on small intestinal bacterial overgrowth in gastrointestinal disorders: An initiative of the Indian Neurogastroenterology and Motility Association - PMC
25. Small Intestinal Bacterial Overgrowth and Childhood Malnutrition: A Comprehensive Review of Available Evidence - PMC
26. Sibo Diet – Dr. Michael Ruscio, DC
27. Hydrogen Sulfide and Methane on Breath Test Correlate with Human Small Intestinal Hydrogen Sulfide Producers and Methanogens - PMC
28. Intestinal methanogen overgrowth and its impact on gastrointestinal disorders in children: a retrospective study - PMC
29. CH4 - Breath test (Trio-Smart) - Lab Results explained | HealthMatters.io
30. Methanogens, Methane and Gastrointestinal Motility - ResearchGate
31. Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease: A Practical Approach to Diagnosis and Treatment of Organic Causes - PMC
32. A randomized double-blind placebo-controlled trial showing rifaximin to improve constipation by reducing methane production and accelerating colon transit: A pilot study - ResearchGate
33. The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time | Request PDF - ResearchGate
34. Role of Small Intestinal Bacterial Overgrowth in Functional Gastrointestinal Disorders - Journal of Neurogastroenterology and Motility
35. Prevalence, risk factors, and treatment of small intestinal bacterial overgrowth in children - PMC
36. Small Intestinal Bacterial Overgrowth-Pathophysiology and Its Implications for Definition and Management - ResearchGate
37. Food, gut barrier dysfunction, and related diseases: A new target for future individualized disease prevention and management - PMC
38. Alternatives to Rifaximin for SIBO: Herbal Antimicrobial Protocols | Lamkin Clinic